Primary Care Diabetes
Volume 2, Issue 1 , Pages 59-61 , 2008

The future of inhaled insulin and incretinmimetics in the management of diabetes

  • Anthony H. Barnett

      Affiliations

    • Department of Diabetes/Endocrinology, University of Birmingham, United Kingdom
    • Department of Medicine, Undergraduate Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham B9 5SS, United Kingdom
    • Corresponding Author InformationCorrespondence address: Department of Medicine, Undergraduate Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham B9 5SS, United Kingdom. Tel.: +44 121 424 3587; fax: +44 121 424 0593.

Received 2 January 2008 ,Accepted 8 January 2008.

References 

  1. Bellary S, Barnett AH. Selection and education of patients for inhaled insulin. Curr. Diabetes Rep. 2007;7:363–368
  2. Inhaled Insulin for the Treatment of Diabetes (Type 1 and 2). NICE Technology Appraisal No. 113, December 2006.
  3. Bailey CJ, Barnett AH. Why is Exubera being withdrawn?. BMJ. 2007;335:1156
  4. Barnett A. Exenatide. Expert Opin. Pharmacother. 2007;8(15):2593–2608
  5. Defronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of Exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with Type 2 diabetes. Diabetes Care. 2005;28(5):1092–1100
  6. Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD Exenatide-113 Clinical Study Group. Effects of Exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with Type 2 diabetes. Diabetes Care. 2004;27:2628–2635
  7. Kendall DM, Riddle MC, Rosenstock J, et al. Effects of Exenatide (exendin-4) on glycemic control over 30 weeks in patients with Type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care. 2005;28(5):1083–1091
  8. Heine RJ, Van Gaal LF, Johns D, et al. Exenatide versus insulin glargine in patients with suboptimally controlled Type 2 diabetes: a randomized trial. Ann. Intern. Med. 2005;143(8):559–569
  9. Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, et al. Tolerability and efficacy of Exenatide and titrated insulin glargine in adult patients with Type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period crossover noninferiority trial. Clin. Therap. 2007;29(11):2333–2348

PII: S1751-9918(08)00002-8

doi: 10.1016/j.pcd.2008.01.001

Primary Care Diabetes
Volume 2, Issue 1 , Pages 59-61 , 2008

Article Tools